Royal Bank of Canada’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-90,000
Closed -$2.17M 6909
2017
Q2
$2.17M Buy
90,000
+73,300
+439% +$1.61M ﹤0.01% 2522
2017
Q1
$331K Sell
16,700
-150
-0.9% -$3.35K ﹤0.01% 3970
2016
Q4
$406K Sell
16,850
-73,960
-81% -$2.06M ﹤0.01% 3926
2016
Q3
$2.52M Hold
90,810
﹤0.01% 2386
2016
Q2
$2.21M Buy
90,810
+20,180
+29% +$572K ﹤0.01% 2458
2016
Q1
$2.37M Sell
70,630
-45,910
-39% -$1.45M ﹤0.01% 2325
2015
Q4
$3.48M Buy
116,540
+9,182
+9% +$309K ﹤0.01% 2108
2015
Q3
$3.38M Hold
107,358
﹤0.01% 1836
2015
Q2
$5.19M Buy
+107,358
New +$4.52M ﹤0.01% 1579

Other funds holding PGEN

Royal Bank of Canada's PGEN Position: Q1 2026 in Review

Royal Bank of Canada increased its Precigen (PGEN) stake by 103% in Q1 2026, buying an estimated $22.3K and bringing the position to 10,714 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #5586.

Royal Bank of Canada first reported a position in PGEN in Q3 2013 and has held it in 46 quarters since. The position peaked at $1.72M in Q3 2015. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Royal Bank of Canada held 10,714 shares of Precigen worth $41K as of Q1 2026.
  • Royal Bank of Canada bought 5,426 Precigen shares in Q1 2026, an estimated $22.3K.
  • Precigen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5586 holding.
  • Royal Bank of Canada first reported a position in Precigen in Q3 2013 and has held it in 46 quarters since.
  • Royal Bank of Canada's Precigen position peaked at $1.72M in Q3 2015.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.